Revenue: The sum of all revenue fields included for a company's operating activities.
Lexicon Pharmaceuticals, Inc. (LXRX) had Revenue of $1.26M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$1.26M |
$-25.30M |
|
$0.03M |
|
$1.23M |
|
$26.94M |
|
$-25.68M |
|
$0.38M |
|
$-25.30M |
|
$-25.30M |
|
$-25.30M |
|
$-25.30M |
|
$-25.30M |
|
$-25.30M |
|
$-25.68M |
|
$-25.10M |
|
362.07M |
|
362.07M |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$245.81M |
|
$2.31M |
|
$51.87M |
|
$297.67M |
|
$110.69M |
|
$58.64M |
|
$63.95M |
|
$174.64M |
|
$123.03M |
|
$78.49M |
|
$123.03M |
|
363.18M |
|
| Cash Flow Statement Financials | |
$-43.78M |
|
$40.58M |
|
$-0.57M |
|
$66.66M |
|
$62.89M |
|
$-3.77M |
|
$3.04M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.22 |
|
-- |
|
-- |
|
0.32 |
|
0.82 |
|
97.62% |
|
-2034.79% |
|
-2034.79% |
|
-- |
|
-2004.36% |
|
-2004.36% |
|
$-43.78M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
0.15 |
|
0.03 |
|
3383.70 |
|
-20.56% |
|
-32.23% |
|
-8.50% |
|
-13.92% |
|
$0.34 |
|
$-0.12 |
|
$-0.12 |
|